Bipartisan BENES 2.0 Act could mean more money in the pockets of long-term care residents
By
Kathleen Steele Gaivin
Feb 22, 2022
Older adults and long-term care residents could end up with more money in their pockets if the Senate’s bipartisan Beneficiary Enrollment Notification and Eligibility Simplification 2.0 Act becomes law....
Providing palliative care to wider group of people, including assisted living residents, gains bipartisan...
By
Kimberly Bonvissuto
Jun 24, 2022
A demonstration project to deliver palliative care no matter where an individual lives — including in assisted living communities — and earlier in the disease process has gained bipartisan support.
Greater nurse staffing tied to better sepsis outcomes
Jun 01, 2022
An increase in registered nurse hours per patient day was associated with a 3% decrease in 60-day mortality.
Medicare will only cover Aduhelm for patients in clinical trials
Apr 08, 2022
The decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking.
SNF occupancy continued slow recovery through December, NIC says
By
Kathleen Steele Gaivin
Mar 08, 2022
Skilled nursing facility occupancy in December 2021 hit its highest level since May 2020, according to data released Thursday by the NIC Skilled Nursing Data Initiative.
Long-term care financing success requires federal program, coverage across continuum: report
By
Kimberly Bonvissuto
Feb 08, 2022
A new federal benefit that would include taxpayer subsidies and cover the continuum of long-term care services, including residential care and home- and community-based services, would address some of...
Medicare beneficiaries can appeal gap in nursing home coverage, court rules
By
Kathleen Steele Gaivin
Jan 31, 2022
Thursday ruling from a three-judge appellate federal court in Connecticut paves the way for hundreds of thousands of Medicare beneficiaries to appeal non-coverage of nursing home care after hospital stays.
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
Seniors report medical care missed during the pandemic
Dec 30, 2021
The rates of forgone medical care because of COVID-19 decreased over time; about 70% of forgone care was due to physician-driven factors.
Biogen cuts price of controversial Aduhelm in half
Dec 21, 2021
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.